Late transcatheter heart valve on multidetector computed tomography

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220281

Enrollment

Registered

2017-03-27

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who had undergone transcatheter aortic valve implantation (TAVI) for aortic stenosis

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who had undergone TAVI in Sakakibara Heart Institute from April 2010 to September 2012

Exclusion criteria

Exclusion criteria: death, no consent, debilitated patient, allergy of contrast material, renal dysfunction (eGFR<45)

Design outcomes

Primary

Measure	Time frame
transcatheter heart valve thrombosis and structural valve deteriorations	—

Secondary

Measure	Time frame
valve hemodynamics on echocardiography	—

Countries

Japan

Contacts

Public ContactRyosuke Higuchi

Sakakibara Heart Institute

rhiguchi@shi.heart.or.jp+81-42-314-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026